THERABLUEPRINT Trademark

Trademark Overview

On Monday, November 4, 2024, a trademark application was filed for THERABLUEPRINT with the United States Patent and Trademark Office. The USPTO has given the THERABLUEPRINT trademark a serial number of 98836155. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 19, 2025. This trademark is owned by ThinkBio.Ai., Inc.. The THERABLUEPRINT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
therablueprint

General Information

Serial Number98836155
Word MarkTHERABLUEPRINT
Filing DateMonday, November 4, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2025

Trademark Statements

Goods and ServicesProviding information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 4, 2024
Primary Code044
First Use Anywhere DateMonday, April 15, 2024
First Use In Commerce DateMonday, April 15, 2024

Trademark Owner History

Party NameThinkBio.Ai., Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeal Beach, CA 90740
Party NameThinkBio.Ai., Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeal Beach, CA 90740

Trademark Events

Event DateEvent Description
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 12, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 4, 2024NEW APPLICATION ENTERED
Friday, May 2, 2025ASSIGNED TO EXAMINER
Tuesday, May 6, 2025NON-FINAL ACTION WRITTEN
Tuesday, May 6, 2025NON-FINAL ACTION E-MAILED
Thursday, June 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 12, 2025NON-FINAL ACTION WRITTEN
Thursday, June 12, 2025NON-FINAL ACTION E-MAILED
Monday, June 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 27, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 27, 2025FINAL REFUSAL WRITTEN
Monday, June 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 30, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 13, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2025PUBLISHED FOR OPPOSITION
Tuesday, August 19, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 27, 2025FINAL REFUSAL E-MAILED

Related Keywords

therablueprint therapeutic properties pharmaceuticals prophylactic diagnostic information relating providing